Baird Affirms Sarepta Therapeutics (SRPT) at 'Outperform'; Incrementally Positive on PTAB Decision (BMRN)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. LLY
2. DAVA
3. MONC:IM
4. MONRY
5. NYXH
6. PNR
7. ONON
8. IAUX
9. KKR
10. VICR

Go back to Baird Affirms Sarepta Therapeutics (SRPT) at 'Outperform'; Incrementally Positive on PTAB Decision (BMRN)
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 64.06 --0 (-0%)
Previous Close $64.06    52 Week High $108.96 
Open $64.06    52 Week Low $62.12 
Day High $64.06    P/E N/A 
Day Low $64.06    EPS $-1.27 
Volume 500       

SAREPTA THERAP (NASDAQ: SRPT) Delayed: 20.14 --0 (-0%)
Previous Close $20.14    52 Week High $63.73 
Open $20.14    52 Week Low $8.00 
Day High $20.14    P/E N/A 
Day Low $20.14    EPS $-5.69 
Volume 1,753